Market Overview

The Global Therapeutic Vaccine Market was valued at USD 41,381.6 million in 2023 and is expected to reach USD 191,408.0 million by 2031 while growing at a CAGR of 21.1% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global therapeutic vaccine market growth. Therapeutic vaccines offer a promising avenue for active immunotherapy in late-stage cancer treatment, harnessing the patient's immune system. This significant advancement not only introduces a novel treatment approach for cancer but also sets the stage for the strategic development and enhancement of future vaccines, aiming for superior anticancer effectiveness.

Advancements in understanding immune system dynamics and tumor immunology, increasing cancer incidence, and a supportive regulatory environment propel market growth. Conversely, high development costs and complex manufacturing processes impede market expansion.

Furthermore, the global therapeutic vaccine industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Technology Analysis

The Global Therapeutic Vaccine Market is segmented among Autologous vaccines, and Allogeneic vaccines, based on Technology. In 2023, Autologous vaccines accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Product Analysis

The Global Therapeutic Vaccine Market is segmented among Addiction Vaccines, Autoimmune Disease Vaccines, Neurological disease vaccines, and Infectious Disease Vaccines, based on Product. In 2023, Autoimmune Disease Vaccines accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Therapeutic Vaccine Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Bavarian Nordic, Argos Therapeutics, Antigenics, Affiris, Celldex Therapeutics, Biovest International, Cel-Sci, Celtic Pharma, Cytos Biotechnology, and Curevac.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Therapeutic Vaccine Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Therapeutic Vaccine Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Therapeutic Vaccine Market Segmentation, By Technology

• Global Therapeutic Vaccine Market Share Analysis, By Technology

• Global Therapeutic Vaccine Market Growth Analysis, By Technology

• Global Therapeutic Vaccine Market Trends, By Technology

o Autologous vaccines

o Allogeneic vaccines

6. Global Therapeutic Vaccine Market Segmentation, By Product

• Global Therapeutic Vaccine Market Share Analysis, By Product

• Global Therapeutic Vaccine Market Growth Analysis, By Product

• Global Therapeutic Vaccine Market Trends, By Product

o Addiction Vaccines

o Autoimmune Disease Vaccines

o Neurological disease vaccines

o Infectious Disease Vaccines

7. Global Therapeutic Vaccine Market Segmentation, By Region

• Global Therapeutic Vaccine Market Share Analysis, By Region

• Global Therapeutic Vaccine Market Growth Analysis, By Region

• Global Therapeutic Vaccine Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Bavarian Nordic*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Argos Therapeutics

• Antigenics

• Affiris

• Celldex Therapeutics

• Biovest International

• Cel-Sci

• Celtic Pharma

• Cytos Biotechnology

• Curevac

*Similar analysis will be provided for each company listed above.